Synthesis of some cyclic indolic peptoids as potential antibacterials

Tetrahedron

Volumn 62, Issue 40, 2006, Pages 9373-9382

  Au, Vicki S ^a   Bremner, John B ^a   Coates, Jonathan ^b   Keller, Paul A ^a   Pyne, Stephen G ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b Avexa Ltd   (Australia)

Author keywords

Antibacterial; Cyclic peptoid; Indole; Ring closing metathesis

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOPEPTIDE; INDOLE DERIVATIVE; METHYL 1,2,3,4,5,6,7,8,9,10,11,12,13,14 TETRADECAHYDRO 1,14 METHENO 8,11 DIOXO 9 (4 AMINOBUTYL) 1,7,10 BENZOTRIAZACYCLOHEXADECINE 6 CARBOXYLATE; METHYL 1,2,3,4,5,6,7,8,9,10,11,12,13,14 TETRADECAHYDRO 1,14 METHENO 8,11 DIOXO 9 (4 GUANIDYLBUTYL) 1,7,10 BENZOTRIAZACYCLOHEXADECINE 6 CARBOXYLATE; METHYL 1,3,4,5,6,7,8,9,10,11,12,13 DODECAHYDRO 1,13 METHENO 8,11 DIOXO 9 (4 AMINOBUTYL) 2H 1,7,10 BENZOTRIAZACYCLOPENTADECINE 6 CARBOXYLATE; METHYL 1,3,4,5,6,7,8,9,10,11,12,13 DODECAHYDRO 1,13 METHENO 8,11 DIOXO 9 (4 GUANIDYLBUTYL) 2H 1,7,10 BENZOTRIAZACYCLOPENTADECINE 6 CARBOXYLATE; METHYL 1,3,4,5,6,7,8,9,10,11,12,13,14,15 TETRADECAHYDRO 1,15 METHENO 8,11 DIOXO 9 (4 AMINOBUTYL) 2H 1,7,10 BENZOTRIAZACYCLOHEPTADECINE 6 CARBOXYLATE; METHYL 1,3,4,5,6,7,8,9,10,11,12,13,14,15 TETRADECAHYDRO 1,15 METHENO 8,11 DIOXO 9 (4 GUANIDYLBUTYL) 2H 1,7,10 BENZOTRIAZACYCLOHEPTADECINE 6 CARBOXYLATE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DEPROTECTION REACTION; DRUG SYNTHESIS; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; RING CLOSING METATHESIS; STAPHYLOCOCCUS AUREUS;

EID: 33747750868     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.07.059     Document Type: Article

References (14)

1. Neu H.C. Science 257 (1992) 1064-1072
2. Nicolaou K.C., and Boddy C.N.C. Sci. Am. 284 (2001) 54-61
3. Noble W.C., Virani Z., and Cree R.G.A. FEMS Microbiol. Lett. 93 (1992) 195-198
4. Guiot H.F., Peetermans W.E., and Sebens F.W. Eur. J. Clin. Microbiol. Infect. Dis. 10 (1991) 32-34
5. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K.V., Murray B.E., Wolff J., and Walters B. Clin. Infect. Dis. 16 (1993) 750-755
6. Sievert D.M. Morb. Mortal. Wkly. Rep. 51 (2002) 565-567
7. Daly J.S., Eliopoulos G.M., Willey S., and Moellering Jr. R.C. Antimicrob. Agents Chemother. 32 (1988) 1341-1346
8. Tsiodras S., Gold H.S., Sakoulas G., Eliopoulos G.M., Wennersten C., Venkataraman L., Moellering R.C., and Ferraro M.J. Lancet 358 (2001) 207-208
9. Gonzales R.D., Schreckenberger P.C., Graham M.B., Kelkar S., DenBesten K., and Quinn J.P. Lancet 357 (2001) 1179
10. Levy S.B., and Marshall B. Nat. Med. (2004) S122-S129
11. Bremner J.B., Coates J.A., Coghlan D.R., David D.M., Keller P.A., and Pyne S.G. New J. Chem. 26 (2002) 1549-1552
12. Bremner J.B., Coates J.A., Keller P.A., Pyne S.G., and Witchard H.M. Synlett (2002) 219-222
13. Bremner J.B., Coates J.A., Keller P.A., Pyne S.G., and Witchard H.M. Tetrahedron 59 (2003) 8741-8755
14. See Refs. 11-13 for additional literature citation of RCM of peptoids.